Ovarian cancer and hormone replacement therapy

Lancet. 2007 Sep 15;370(9591):932; author reply 932-3. doi: 10.1016/S0140-6736(07)61436-6.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Female
  • Hormone Replacement Therapy / adverse effects*
  • Humans
  • Ovarian Neoplasms / chemically induced*
  • Patient Selection
  • Postmenopause
  • Risk Factors